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S u m m a r y
• Data in this report relates only to Opioid-Related Deaths due to unnatural
causes investigated by the Dublin City and County Coroners.
•   The source of the data was the files of the offices of the Coroners, which
contain all the evidence presented at inquests into such deaths.
•   The Dublin City and County Coroners conducted 645 inquests in 1999. 86
(13.33%) were deemed to have been Opioid-Related Deaths. A detailed
examination was conducted on the files of these cases.
• The characteristic profile of opioid-related deaths as predominantly affecting
those young, male, single and unemployed established in the 1998 survey is
continued in 1999. The male: female ratio was 8.55:1.
• Only 7 decedents (8.13%) had a singular drug implicated in their deaths.
91.87% of decedents had 2 or more drugs (up to a maximum of 7 in one case)
implicated in their deaths with an average of 3.38 drugs implicated per death.
• For the second year running benzodiazepines were implicated in the highest
number of deaths. 73.3% (n=63) of cases proved benzodiazepine positive at
toxicology.
• A rise of 9.17% was found in the percentage of cases proving positive for
heroin. 57 (66.27%) cases were found to have heroin implicated. This
contrasts with a percentage decrease of 11.55% in the number of cases where
methadone was implicated - 54.65% (n=47). ..
• In 68.6% (n=59) of cases the deceased were known to have used or to have
been addicted to opiates before their death.
•   It appears that death occurred almost instantly or soon after injection of heroin
in 25.58% of cases (n=22). .
• 55.8% (n=48) were apparently alone when taking the drugs, which contributed
to their death. .
•   7 of the people who died were either on temporary release or had been recently
released from prison. However 1 person died in Mountjoy Prison and a second
. collapsed there and later died in the Mater Hospital. .
• 11 cases (12.79%) were apparently opioid-related suicides.
• It is clear that some opiate-related deaths are potentially preventable. A range .
of relatively simple and for the most part inexpensive interventions could
reduce the incidence of such tragedies. These interventions include both
improved quality and range of services for and greater dissemination of risk
factors to opiate users.
The use of opiates is associated with substantial morbidity and mortality from
overdose, blood borne infectious deceases and environmental factors such as accidents
and increased exposure to violence (Strang et al, 1999; Hulse et al., 1999). It is
essential to monitor the frequency and circumstances of opioid-related deaths and
trends in opioid mortality rate, as these have implications for the provision of
prevention and treatment services (Walsh, 1991). Coronial investigations allow a deep
insight into this subject and they can also serve as an indication for epidemiological
developments, preventive strategies and clinical care (Piischel, 1993).
This report outlines the findings of the second in a series of surveys on the inquest
files of the Dublin City and County Coroners. The role of the coroners in investigating
deaths due to unnatural causes in their jurisdictions brings them into sometimes-daily
contact with the most tragic consequences of the use of opiates. The report aims to
collate and disseminate the evidence on causes, circumstances and contributing
factors, presented to them at inquests into such deaths.
The nature and extent of opioid-related deaths investigated by the coroners in 1999
will be documented. A national and international context will be profiled and a range
of preventive measures discussed. It is hoped that the report will inform and guide
policy makers and practitioners attempting to reduce the harms associated with drug
taking and encourage the development of prevention strategies against the ultimate
drug related harm - premature mortality. . . . . .:
Introduction
Background
Throughout the '90s the trend in the number of drug-related deaths has risen in Ireland
at a higher rate than in any other country in the European Union (EMCDDA, 1999).
While this marked increased may be partly due to under-reporting in the early part of
the decade, it must reflect also, the increase in the number of people abusing opiates in
Ireland during this period. It was estimated that there were 13,460 opiate users in
Dublin in 1996 and for planning purposes it was deemed prudent to presume that there
were approximately 10,500 to 12,500 (Comiskey, 1997). More recently it was
estimated that in Ireland there was between 2.2 and 6.7 problem drug users per 1000
population between the ages of 15 and 54 (EMCDDA, 1999). .
Addicted heroin injectors face a risk of death which may be 20 or 30 times higher than
in the general population of the same age (EMCDDA, 1997a). Overdose remains the
leading cause of death among drug injectors (EMCDDA, 1997b). However, because
ambiguities remain concerning the role of drug purity, individual tolerance and
polydrug co-abuse in such deaths, the World Health Organisation has cautioned
against the use of the term "overdose"(WHO, 1993). They recommend instead the use
of the ICD-10 classification (WHO, 1992) of "acute intoxication".
In recent years the Eastern Health Board has taken the core of the evidence on the
effectiveness of methadone maintenance and attempted to develop a range of services
to ensure higher levels of treatment access (Farrell et al, 2000). By the end of
February 2000 there were 4,353 people receiving methadone treatment in its
catchment area. While international evidence indicates that methadone maintenance
has a substantial protective effect on mortality from opiate overdose, there is also
evidence that people in opioid substitution programmes may be at risk of overdose
(WHO, 1998). This can occur when, for example, tolerance is incorrectly assessed,
when doses are combined or when combinations of other drugs are taken. Methadone
overdose deaths can also occur when therapeutically prescribed methadone is diverted
and used by non-opioid tolerant individuals (Hall et al., 2000).
On the 1st of October 1998 the Misuse of Drugs (Supervision of Prescription and
Supply of Methadone) Regulations were introduced. By registering those presenting
for treatment and by regulating the prescription and dispensing of methadone it was
intended that 'The Methadone Protocol' would substantially reduce the problem of
diversion from legitimate sources here. Future surveys may confirm its success in
achieving this goal. :
The criteria for the definition of a "drug-related death" can be based on: (a) clinical
and toxicological criteria, such as the type of substance used and the route of
administration; (b) the circumstances surrounding the death; and (c) whether the
person is known as a drug addict. However, different countries place different .
emphasis on aspects of these criteria and consequently the definition of a drug-related
death adopted in various countries may differ (EMCDDA, 1997b). The lack of a
common terminology or classification system has been seen as one of the major
problems for international comparisons of drug-related mortality data (WHO, 1993).
In Ireland such data is classified using the ninth revision of the International
Classification of Diseases and related health problems (WHO, 1977). The introduction
of ICD-10 may improve the classification and coding of drug-related deaths. The
inadequacies of earlier ICD classification to capture opioid-related deaths may in part
explain the lack of reliable and comparable international data (WHO, 1998).
The causes of and risk factors associated with drug related deaths appear now to be
more varied than was previously perceived. Deaths attributed to heroin overdose, for
example, are likely to have morphine levels no higher than those in non-fatal
overdoses (Darke and Zador, 1996). Also, the span of blood concentrations of victims
of methadone overdose overlaps that of methadone maintenance subjects (Baselt and
Cravey, 1995). Therefore, quantity or purity alone cannot explain the cause of death in
these cases.
Variations in individual tolerance are likely to be an important factor in opioid
overdose deaths (NDARC, 1998). After periods of abstinence individual tolerance to
opiates is lowered and opiate users are particularly vulnerable to overdose after release
from prison (Seaman et al, 1998) and when they leave or 'drop out' of treatment
programmes (Zanis and Woody, 1998; Davoli et al., 1993). It has also been suggested
that variation in rate of metabolism due to genetic factors could explain differential
sensitivity to overdose (White and Irvine, 1999).
However, polydrug misuse, particularly the concurrent misuse of benzodiazepines
and/or alcohol with opiates, is a major overdose risk factor (EMCDDA, 1999;
NDARC, 1998; WHO, 1998). In fact, fatalities solely involving opiates appear to
form a minority of such overdose deaths. The respiratory depressant effects of opiates
' are heightened by the concurrent use of other central nervous system depressants such
as benzodiazepines and alcohol (Darke and Zador, 1996).
Finally, opiate users are generally in poorer health than their peers and this may
increase their vulnerability to overdose death (WHO, 1998). Apart from HP/ and
hepatitis B and C infection prevalence, medical complications common among opiate
users include septicaemia, endocarditis, malnutrition and pulmonary, cerebral, and
subcutaneous abscesses (Ward et aly 1998).
Methodology
Number of Inquests Held and Cases Extracted
The Dublin City Coroner conducted 462 inquests and the Dublin County Coroner
conducted 183 inquests in 1999. The total of 645 represents-a slight percentage
decrease (2.72%) on the total number of inquests held in the city and county for 1998
(n=663). Between the 10th and the 18th January and between the 24th January and the
1st of February 2000 the files of these 645 inquests were examined in the offices of the
coroners. Of these 86(13.33%) were identified as having opiates implicated in the
death and were extracted for further examination. In 1998 77 cases were extracted
from 663 (11.61%) indicating an increase in 1999 of 1.27%.
The length of time between the date of death and date of inquest for the extracted
cases in the Dublin City Coroner's Court in 1999 ranged between 1 month and 4 years
with an average of 10 months, an increase of 2 months on 1998. The length of time
between the date of death and date of inquest in the Dublin County Coroner's Court in
1999 ranged between approximately 2 and 20 months with an average of 61/2 months,
an increase of 2lA month on 1998. - - .
Additionally, the Kildare County Coroner was also interviewed on the 5  of April.
After prior correspondence he had identified 8 cases (from the 82 inquests he
conducted in 1998 and 1999), which may have interested the project. The files of 3 of
these cases were scrutinised but it was decided that none of them was suitable. The
Coroners for East and West Wicklow were also contacted. In telephone conversation
with each of these it was deduced that there had been no qualifying case in the West
of the County and that there may have been one methadone-implicated death in the
East of the County in 1999.
Case Selection Criteria
As stated earlier, there seems as yet to be no standardised international definition of a
drug related death. The primary concern of this research project, however, is
premature mortality related to the use of opiates. Files were extracted for further
examination when any or all of the following criteria were met:
• On determining the cause of death the coroner specifies opiates.
• Opiates are implicated in pathology or toxicology examinations.
• A history of, use of or treatment for addiction to opiates is indicated in depositional
evidence (i.e. evidence presented at inquest). .
. • Alcohol or other drugs are implicated additional to any or all of the first 3 criteria
being met
Data Extracted and Coding
A standard form was completed for each case (appendix). Information was collected
on demographics, cause and circumstances of the death. Full toxicological details
were extracted and additional observations on a range of potential contributory factors
were noted.
Depositional evidence presented to the Coroners at inquest provide valuable insights
into the circumstances of the death and background information on the deceased
which may or may not have contributed to their premature demise. For example,
police officers will present evidence concerning the circumstances of finding the
body, any evidence found at the scene and whether the deceased was known to them
or not. Family members and friends may give evidence of events prior to the death
and of the state of mind and personal history of the deceased. Background medical 
evidence may be presented which might state for example that the deceased was a  :
known drug addict and whether they were being treated for this or for any drug-related
illness. A more in depth analysis was carried out on such evidence in the current .
survey than in 1998. .
 : . . . . • - . , .
In the first survey of the 1998 files of the Dublin City Coroner no information that
would personally identify the deceased was extracted. In order to facilitate
comparability with statutory public health databases, personal identifying details were
collected in the 1999 survey. However, each case has been anonymised in all project
documents for public consumption. A detailed copy of all the information extracted
and compiled on each case has been returned to the Coroners. The research project
will maintain paper and electronic versions of this database secure and in the strictest
of confidence. Requests for access to the database will be referred to the offices of the
coroner. . . . . •-. . . . .
All cases were coded for District Electoral Division (DED). Total and standardised
population statistics for each DED were obtained from the census of population 1996.
Opioid-related death (ORD) rates/1,000 total and standardised population were
calculated for each DED and a rate of unemployment was established.
Additionally cases were coded for Local Drug Task Force Area (LDTFA). The First
Report of the Ministerial Task Force on Measures to Reduce the Demand for Drugs
(1996) recommended the establishment of a Drugs Task Force in each of these areas
identified as having the most acute heroin problem and therefore requiring priority
action.
To facilitate future comparison with national and international databases cases were
coded by both ninth and tenth revisions of the International Statistical Classification
of Diseases, injuries and causes of death (ICD9 and ICD10).
LResults
Demographics
The characteristic profile of opioid-related deaths as predominantly affecting those
young, male, single and unemployed established in the 1998 survey is continued in
1999. 95.3% of cases were between the ages of 15 and 44. They ranged between 17
and 48 and the mean age was 29.73 (up 2.68 years on 1998). The male: female ratio
was 8.55:1, an increase of 90% on the ratio for the previous year - 4.66:1 (figure 1).
The reason for this massive increase is unclear. Males are typically over-represented
in fatalities attributed to overdose, ranging up to over 80% of recorded fatalities in
some international studies (Darke and Zador, 1996). Further surveys may confirm if
the 89.5,% male dominance in the current survey is an oddity or part of a trend. In
1998 92.2% of cases were between the ages of 15 and 44. They ranged from a child of
3 who may have consumed some methadone, which had been prescribed to his
parents, to a 60 year old man who died of respiratory failure following consumption of
methadone.
The current survey reveals that 75.6% of decedents were single and that 70.9% were..
unemployed. An average unemployment rate of 11.17% was found in the 54 DEDs
with one or more ORDs, ranging from 25.98% in the DED of Mountjoy B to 2.53% in
the DED of Ballyboden (table 1). Over 93% of decedents resided within broader areas
identified by the state as having the most acute heroin problem (LDTFAs).
Figure 1.
Age and Sex distribution in Opioid-Related Deaths:
1999 1998
I Male I Female
Opioid-Related Death (ORD) Rates
The North and South inner city Local Drug Task Force Areas (LDTFA) are again
prominently affected with 9 and 7 deaths respectively (figure 2). Dunlaoghaire/
Rathdown and Tallaght both had 9. While the Canal Communities and Clondalkin
areas had 8 each. However in 1999 Ballymun predominates with 10 deaths (an
increase o f 8 o n 1998). . . .
Figure 2.
Local Drug Task Force Areas - Opioid-Related Deaths
11999 E1998
However, when an opioid-related death (ORD) rate per 1000 total population is
calculated for each DED a different picture begins to emerge. The highest rate (1.3)
was in the DED of Merchants Quay F with 3 ORDs from a total population of 2296.
Merchants Quay F is in the Canal Communities LDTFA. The Lowest rate (0.1) was in
the DED of Clondalkin-Dunawley with 1 ORD from a total population of 9289 (table
When a total of standardised ORD rates per 1000 population between the ages of 15-
44 for all DEDs in each LDTFA is established, further clarity emerges. With a total of
8.16, Canal Communities predominates showing almost a 400% increase on 1998.
While the North Inner City total is down from 9.6 to 6.29 it still has the second
highest total. Dunlaoghaire/Rathdown comes next with a rate of 6.03. Ballymun,
Dublin 12 and South Inner City follow these with 5.74, 5.74 and 4.93 respectively
( T a b l e  2 )
Classification of Cause of Death
(A):ICD9.
Using the ninth revision of the International Statistical Classification of Diseases, the
cause of death was categorised, in the majority of cases (57%) in 1999, as being "drug
dependence" (304). The fourth character subdivisions .0, .7 and .8 refer to 'morphine
type', 'combination of morphine type with any other' and ^excluding morphine type
drug' respectively. In 1998 the ICD9 code 304 was attributed to 49.4% of cases (table3)
The cause of death was categorised as "Nondependent abuse of drugs" (305) in 25.6%
of deaths in 1999 compared to 45.5% in 1998. This percentage reflects the totals of
those who were not known to have used or been addicted to opiates and those where
no depositional evidence was presented on this matter (reported below). However, the
high percentage recorded for 1998 may reflect the fact that this specific question was
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(B):ICD10.
Using the tenth revision of the International Statistical Classification of Diseases the
cause of death was categorised, in the majority of cases (52.3%) in 1999, as "Mental
and behavioural disorders due multiple drug use..." (F19.0), The fourth character
subdivisions .0 and .2 refer to acute intoxication and dependence syndrome
respectively. In 1998 the ICD10 code F19.0 was attributed to 50.6% of cases (table 4).
"Accidental poisoning by and exposure to narcotics and psychodysleptics
(hallucinogens) not elsewhere classified" (X42) was the cause of death in 26.7% of
deaths in 1999 and 32.5% in 1998. "Mental and behavioural disorders due to use of
opioids" (Fl 1.0 and Fl 1.2) accounted for 3.5% in 1999 and 13% in 1998. Intentional
self-poisoning (X62) and intentional self-harm by hanging (X70) or jumping from a
high place (X80) accounted for 2, 8, and 1 death respectively (12.8%) in 1999
compared to 3.9% in 1998. Other causes including assault by shotgun or sharp object
(X94 or X99) and drowning (W69) accounted for 4.7% in 1999. .
Circumstances and Potential Contributory Factors
In 68.6% (n=59) of cases the deceased were known to have used or to have been ;
addicted to opiates before their death. 16.3% (n=14) were not known to have used or
to have been addicted to opiates, hi 14.8% (n=13) of cases no depositional evidence
was presented on this matter. .
It appears that death occurred almost instantly or soon after injection of heroin in
25.58% of cases (n=22). Evidence was presented of syringes being found in or next to
the body; of tourniquets still tied around the arm, the wrist or the thigh and of
injection paraphernalia found next to the body.
55.8% (n=48) were apparently alone when taking the drugs, which contributed to then-
death. 25.6% (n=22) were in company and in the remaining 18.6% of cases (n=16) it
was not possible to ascertain from depositional evidence whether they were alone or
not
Whether or not the deceased had been prescribed drugs proven positive at toxicology
is not always apparent from depositional evidence. However it was stated that 32.6%
not asked in the first survey of the Dublin City Coroners inquest files. The ICD 9 code
305 refers to the maladaptive effects of a drug on which a person is not dependent and
that was taken on their own initiative (WHO, 1972). The fourth character subdivisions
.5, .6, .7 and .9 refer to 'morphine type', 'cocaine type', 'amphetamine type' and
'other, mixed or unspecified' respectively.
Suicide and self-inflicted poisoning (E950) or injury by hanging (E953.0) and by
jumping from a high place (E957.0) accounted for 2, 8 and 1 death respectively
(12.9%) in 1999 compared to 3.9% in 1998. Other causes including: assault by
shotgun or cutting and piercing instrument (E965.0 or E966); accidental drowning
(E910.9) or accidental poisonings by opiates and related narcotics (E850.0) accounted
for 4.7% in 1999 and 1.3% in 1998.
(n=28) were being prescribed methadone, benzodiazepines or antidepressants. It
appears that 30.2% (n=26) were not being prescribed these drugs and in 37.2% of
cases (n=32) it was not possible to deduce either option from the evidence presented.
Seven of the people who died were either on temporary release or had been recently
released from prison. However 1 person died in Mountjoy Prison and a second
collapsed there and later died in the Mater Hospital. In 1998 1 person died in
Mountjoy and 9 decedents had been recently released or were on temporary release
from prison.
In what were apparent suicide cases or indeed the coroners stated so as cause of death,
7 people were found hanging. 3 of these cases proved positive at toxicology for heroin
and 1 for methadone. Depositional evidence was presented of heroin use in 1 case and
of methadone maintenance treatment in 2 cases. Suicide notes were found in 3
separate cases of polydrug overdose. Depositional evidence was presented in an
additional case of a statement of suicide intent and a history of suicide ideation and
attempts. This person, who was on methadone maintenance treatment at the time,
seems to have jumped from a high building. In total 11 cases (12.79%) were
apparently opioid-related suicides.
Drugs Implicated in Opioid-RelatedDeaths
A drug is deemed implicated when it has been proven positive at toxicology or when
evidence was presented that the drug had been consumed. However, this is not to infer
that the presence of this drug is deemed to have been the cause of death, although it
may have been. It merely implies that it may have been a contributing factor in the
death.
Only 7 decedents (8.13%) had a singular drug implicated in their deaths: 3 heroin, 2
benzodiazepines and 1 each for methadone and alcohol. Concentrations of 5.74|ig/ml,
>25u.g/ml and 0.54jig/ml total morphine were found at toxicology in the urine
samples of the three cases where heroin was the only drug implicated. Concentrations
of 0.21jig/ml and 6.7u.g/ml free morphine were also found in the urine of the first two
 of these cases. In the case where methadone was the only drug implicated, the urine
contained 1.3jig/ml methadone and was also positive for its unique urinary metabolite
EDDP. A blood sample in this case contained 0.4p,g/ml methadone.
One decedent had 7 separate drugs implicated in his death. In a further 3 cases 6 drugs
were implicated. 5,4,3 and 2 drugs were implicated in 16(18.6%), 22(25.58%),
20(23.3%) and 17(19.8%) cases respectively.
 For the second year running benzodiazepines were implicated in the highest number
of deaths (figure 3). 73.3% (n=63) of cases proved benzodiazepine positive at
toxicology in 1999. This represents an increase of 22% on the 1998 figure of 64.7%
(n=55). Diazepam was by far the most implicated benzodiazepine followed by
flurazepam and a few mentions each for flunitrazepam and bromazepam.
Figure 3.
     Drugs implicated in Opioid-Related Deaths
A rise of 9.17% was found in the percentage of cases proving positive for heroin. In
1999 57 (66.27%) cases were found to have heroin implicated compared to 44
(57.1%) in 1998. This contrasts with a percentage decrease of 11.55% in the number
of cases where methadone was implicated from 66.2% (n=51) in 1998 to 54.65%
(n=47)inl999.
Codeine was in all cases but one the opioid analgesic implicated in 47.7% (n=41) of
cases in the current survey, the remaining case implicating dextropropoxyphene. All
but one of these cases had heroin implicated concurrently, the remaining case proved
positive alongside methadone.
The presence of alcohol was detected in 43% (n-37) of cases in the current survey and
41.6% (n=32) in 1998. The amount of alcohol detected again varied greatly. These
range from the highest case with 401mgs% urine content and 279mgs% blood content,
to the lowest case with only 1 lmgs% and 3 lmgs% urine and blood content
respectively (the current blood alcohol drink-driving limit in this country is 80mgs%).
In both these cases alcohol is implicated concurrently with heroin.
There was a small decrease of 3.84% in the amount of cases where antidepressants
were implicated. All 9 cases (10.46%) in the current survey had tricyclic
antidepressants implicated. One of these cases had the Selective Serotonin Reuptake
Inhibitor (SSRI) fluoxetine implicated concurrently. Only one of the 11 cases
implicating antidepressants in 1998 did not prove positive for tricyclics. hi this case
the Monoamine Oxidase Inhibitor (MAOI) moclobemide was implicated.
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There was a rise in the number of cocaine-implicated deaths from 2 (2.6%) in 1998 to
6 (7%) in 1999. In all of these deaths cocaine was concurrently implicated with
heroin. Cannabis has fallen from 22.07% to 15.11 %. Finally, other drugs were 
implicated in 16.27% (n=14) of cases in 1999. These included antipsychotics, ' .
decongestants, amphetamines, barbiturates and paracetamol. , .
Analysis and interpretation of findings
Poly drug Misuse and Benzodiazepines
Polydrug misuse has been consistently verified in international research as a major
risk factor in drug related deaths (EMCDDA, 1999; WHO, 1998; NDARC, 1998). It
has been established that the concurrent use of opiates and other central nervous
system depressants (primarily alcohol and benzodiazepines) is more likely to lead to
fatalities than the use of opiates alone (Hall et al., 2000; Darke and Zador, 1996).
91.87% of decedents in the current survey had 2 or more drugs (up to a maximum of 7
in one case) implicated in their deaths with an average of 3.38 drugs implicated per
death. .. ...
A recent external review of drug services for the Eastern Health Board highlighted a
major problem with polydrug misuse among those in treatment in its catchment area.
It recommends urgent and concerted attention be paid to the fact that in a sample of 5
clinics, over a 4 month period in 1999, a 65% benzodiazepine positive urinalysis rate
was recorded (Farrell et al.9 2000). The toxicology results presented above
dramatically underline the need for such urgency. Benzodiazepines are once again
predominantly implicated in opioid-related deaths investigated by the Dublin City and
County Coroners; 7.03% (n=6) more than heroin and 18.65% (n=16) more than
methadone. Dr. Michael FarreU's team recommends a prescribing audit within and
external to the drug treatment services. They warn that '...action may need to be taken
to restrict benzodiazepine prescribing if the current high levels of misuse are to be
contained' (Farrell et al, 2000, p.33).
Heroin 
A State Laboratory Test Report interpretation of results in a case reported in the first
survey cited a review of 40 cases of death due to injection of diamorphine by addicts.
Urine total morphine levels ranged from 0.1-120|ig/ml (mean 13.2, 23 cases)(Clarke,
1986). However, in the 3 cases reported in the current survey where heroin was the
only drug implicated, while their urine total morphine levels were within this fatal
range, only one of them was known to have been an addict. She was found to have
had not less than 25[xg/ml total morphine in her blood. The next was not known to
have been an addict and 0.54|ag/ml total morphine was found in his blood. In the last
case it could not be determined from the evidence presented whether or not he was an
addict and 5.74jig/ml total morphine was detected. It is clear that quantity and purity
of heroin injected alone cannot predicate mortality risk and that individual tolerance
and susceptibility must also be a determinant.
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The same State Laboratory interpretation also cites a study of multiple variables .
" common to 200 morphine induced fatalities which found that the most reliable 
predictor for overdose death was the presence of blood unconjugated (free) morphine
levels that were greater than 0.24ug/ml (Spiehler, 1989). Blood free morphine was
detected at toxicology in 24 of the 57 cases where heroin was implicated in the current
survey. 75% (n=18) of these were found to have free morphine levels exceeding
0.24jig/ml (range 0.28-0.81, mean 0.53). While these levels may have predicted . . -
overdose alone the average of 2.12 (range 1-4) additional drugs implicated in each
case undoubtedly enhanced their mortality risks. 
Methadone .Twenty two cases had both heroin and methadone implicated in their death in 1999.
The relationship between the rise in the number of heroin implicated deaths and the
fall in the number of methadone-implicated deaths between 1998 and 1999 may or
may not be of significance. However, the introduction of The Misuse of Drugs
(Supervision of Prescription and Supply of Methadone) Regulations (The Methadone
Protocol) may have affected the availability of street/diverted methadone and
consequently have influenced this trend.
In an effort to determine the impact of methadone diversion on the numbers of :
methadone-implicated deaths in Dublin in 1999 a database cross-reference audit was
conducted with the central patient methadone treatment list. Since the introduction of
The Methadone Protocol a registered medical practitioner intending to prescribe 
methadone must notify the Eastern Health Board. The Board maintains the Central
Treatment List and it will inform the practitioner as to whether the person has
previously been registered. It will then issue a treatment card to the person. The
practitioner can only issue a prescription for methadone to a person with a valid 
Methadone
Names, sex, address, age and dates of death of the 47 decedents who had methadone
implicated in their death were supplied to the Eastern Health Board AIDS/DRUGS
Services. It was confirmed that 21 (44.68%) of these were on the central patient
methadone treatment list at the time of their death. However only 23 of the 47
methadone-implicated deaths recorded in 1999 occurred after the introduction of the
methadone protocol on the 1st of October 1998. As everyone receiving methadone
must now be registered, a repeat of this exercise on the findings of the 2000 survey
should provide a clearer indication of the success of the protocol in curtailing
diversion. A breakdown of the numbers of people receiving methadone treatment
within each LDTFA at the end of February 2000 can be found in table 2.
In the one case where methadone was the only drug implicated a level of 0.4ug/ml
was detected in the blood. The span of blood concentrations of victims of methadone
overdosage overlaps that of methadone maintenance subjects and it is difficult, if not
impossible to distinguish between the two on this basis alone. In one survey blood
methadone concentrations averaged 0.28jig/ml (range 0.06-3.1) in 59 victims of fatal
methadone overdosage; in comparison, blood levels averaged 0.11ug/ml (range 0.03-
0.56) in 62 methadone maintenance subjects included as controls (Baselt and Cravey,
1995). The average blood concentration in methadone related deaths investigated by
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the Dublin City and County Coroners in 1999 was 0.51 jig/ml (range 0.08-2.2).
However, an average of 3.57 (range 0-6) other drugs were implicated in each of these
deaths
The level of methadone implication in opioid-related deaths in Dublin gives cause for
concerns (54.65% in 1999 and 66.2% in 1998). However, because of the difficulties in
quantifying the prevalence of opiate use, comparative aggregate mortality risk
estimates between methadone and heroin are hindered by inherent methodological
impediments. Furthermore, how many people would have died in Dublin in 1999 if
they had not been receiving methadone treatment? It is impossible to answer this and
in the absence of longitudinal cohort studies here, comparative mortality rate
estimates between untreated heroin users and those in methadone maintenance
treatment cannot be calculated either. Meanwhile, programmes must aim to maximize
the protective effects of methadone and minimize its contribution to opioid overdose
(WHO, 1998).
Some internationally work has been done in this area. One study followed up a cohort
of 307 heroin addicts admitted into a methadone programme in the early 1970s. They
found that subjects were nearly three times as likely to die outside of methadone
maintenance as in it (Caplehorn et al, 1994). In New South Wales between July 1990
and December 1995 the overall mortality rate among methadone participants was only
26% of the rate reported in studies of untreated heroin users (Sunjic et al, 1998). In
Stockholm it was found that addicts who had never been on methadone maintenance
had a mortality risk 3 times greater than those in treatment (Fugalstad et al, 1995).
This confirmed the earlier Swedish findings highlighting the protective effects of
methadone treatment against drug related mortality (Gronbladh et al, 1990).
While comparing trends in opiate-related deaths in the U.K. and Australia between
1985 and 1995 Hall et al (2000) found that methadone appeared to contribute to 50%
of these deaths in the Britain. This is comparable with the 54.65% of methadone-
implicated deaths found in Dublin in 1999. They concluded that greater availability
and ease of access to methadone maintenance contributes to both a lower rate of
opioid overdose mortality and to a higher rate of methadone implication in such
deaths. The proportional increase in the number of methadone-related deaths to the
increase in the number of persons enrolled in methadone treatment has been
previously highlighted (NDARC, 1998; Neeleman and Farrell, 1997). .
Opiate overdose prevention strategies might therefore include the apparent
contradictory elements of greater availability and ease of access to methadone
maintenance, alongside stringent compliance with proven safe clinical practice. The
challenge to service providers is to develop safer and more accessible methadone
maintenance regimen. .
Antidepressants
The continuing moderate level of antidepressant-implicated deaths merits vigilant
monitoring. Tricyclic antidepressants were implicated concurrently with
benzodiazepines in 10.46% of cases (n=9) recorded in 1999. 6 of these also had
methadone implicated and in the remaining 3 heroin was implicated concurrently. 6 of
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these decedents were being prescribed antidepressants, 1 was not and in the other 2
cases it was not possible to determine from evidence presented whether or not these
were being prescribed.
In a sample of 5 clinics in Dublin over a 4-month period in 1999 a 14% tricyclics
positive urinalysis rate was recorded (Farrell et al, 2000). A survey in Sydney in 1998
found that 21% of subjects had used antidepressants in the previous 6 months (Darke
and Ross, 2000). They found that among injecting drug users antidepressant use was
associated with higher levels of polydrug use, higher levels of psychiatric distress and
a greater risk of heroin overdose. This excess risk of overdose was specifically
associated with tricyclics, rather than SSRIs. They concluded that if it is considered
appropriate to prescribe antidepressants to injecting drug users, it would appear safer
to prescribe SSRIs.
Darke and Ross (2000) also found that as with benzodiazepines, antidepressants are
used by injecting drug users for a variety of reasons not associated with depression per
se. Psychiatric comorbidity amongst drug misusers entering treatment has been linked
to poorer outcomes (Scott et al, 1998). While a psychiatric evaluation is part of the
assessment process for methadone maintenance, a more comprehensive psychiatric
comorbidity audit within the drug treatment services might be of benefit in
determining the actual prevalence of depressive disorders.
Suicide
Depression is by far the most common and consistently reported example of elevated
psychiatric comorbidity among opiate users (Ward et al, 1998). Common with other
factors associated with the misuse of drugs, depression is known to predispose
individuals to suicide (Neale, 2000). Suicide risk among substance-abusing young
people is correlated with the presence of depression and suicidal ideation (Farrell et
al, 1996). However, none of the 9 antidepressant-implicated cases cited above are
included in the 11 apparent opioid-related suicide cases identified in the current
survey.
Nine male and 2 female decedents seem to have taken their own lives. The Coroners
returned verdicts of suicide in 5 of these cases. Open verdicts were returned in 2 cases.
In the first of these the cause of death was given as 'Shock and haemorrhage due to
multiple injuries'. These were caused by a 'fall' from a third floor balcony. This
known heroin addict who was receiving methadone treatment was also a heavy
drinker. She had a history of depression and suicide ideation. A companion became
concerned and momentarily returned to the flat to inform others present that she
thought the deceased was going to jump. In the second case where an open verdict
was returned the cause of death was 'Asphyxia due to hanging and drug overdose'.
This 34-year-old man was found hanging by his 8-year-old son. He was facing a 5-
year prison sentence and was struggling to 'get his head together' for his childs first
holy communion.
Three separate cases of 'Asphyxia due to hanging' were recorded. Two of these were
suffering from depression and the third was described as a chronic heroin addict who
had a history of suicide attempts. In the final case a verdict of misadventure was
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returned. The cause of death was 4 Acute CardioRespiratory Failure due to the
combined toxic effects of benzodiazepine and opiate compounds'. This 21 year old
man had a history of overdosing and suicide ideation. He had consumed methadone, -
'a load of tablets' and 'a bit of gear as well'. He was barred from the family home but
had left suicide notes for his parents and brothers..
While their motivation is not always apparent, common to young people who commit
suicide in the general population, the desire to achieve relief from pain and to escape
unbearable situations (Hill, 1995) seem to predominate. Evidence was presented of
them finding it hard to overcome their addiction. The notes left for loved ones by two
separate decedents serve as poignant insights into their states of mind. One declares,
"...I've lost control, I don't want to end up an everyday junkie; I can see no future in
it; I'm sick of fighting it". The second wrote, "...at last my nightmare is over; with me
being on drugs, I didn't realise how much I loved you's; I don't know what else to do;
I cannot live like this anymore; I have no life".
In Britain suicide among addicts has been estimated at 20 times more likely than in
the general population (Gunnell and Frankel, 1994). Polydmg misuse may lead to a
more than 40-fold increase in suicide risk (Appleby, 2000). This higher risk concurs
with the findings of Oyefeso et al. (1999) who examined suicide trends among
registered addicts in Britain over a 25-year period and who also found that prescribed
drugs, notably antidepressants and methadone, influence this heightened risk. They
believe that greater vigilance should be demonstrated in prescribing and dispensing of
methadone. Given that early diagnosis and treatment of psychiatric disorders are
important factors in suicide prevention they recommend that routine assessment of
addicts should include assessment of suicide risk.
Solitary and Instantaneous Deaths
A "typical" death by opioid overdose is rarely solitary or instantaneous (WHO, 1998).
Being present at an overdose is something that is extremely likely to occur in a heroin
user's career (Darke et al., 1996). Studies of fatal and nonfatal overdoses suggest that
the majority of deaths attributed to overdose occur in the company of others (Darke
and Zador, 1996). In one survey 80% of subjects who self-reported they had
overdosed had done so in the presence of someone else (Powis et al., 1999). However,
from the evidence presented at inquest, it appears that only 25.58% (n=22) of
decedents in the current survey were in the company of others when taking the drugs
that contributed to their deaths. Of the 57 heroin-implicated deaths only 22.8% (n=13)
were accompanied.
Also it appears that instant death following the administration of heroin is not the
norm. Of 152 heroin-related deaths in New South Wales in 1992, 14% of cases were
classified as instant (Zador et al., 1996); and the time lapse between administration of
heroin and death is commonly reported to be greater than 2-3 hours (Darke and Zador,
1996). However, in 21 (36.84%) of the 57 heroin-implicated cases in the current
survey it appears that death occurred almost instantly or soon after injection of heroin.
It is not possible to ascertain from the evidence presented at inquest why a greater
percentage of people seem to have died instantly after administration of heroin here
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than in the surveys cited above; or why a greater percentage of them seemed to have
died alone. These matters warrant further investigation. The time between
administration of heroin and death presents an important opportunity for intervention.
However, there may be a reluctance on the part of witnesses to overdoses (commonly
other heroin users) to seek assistance (Darke and Zador, 1996; Strang et al., 1996).
Just 27% reported ambulances having been called in Powis et al. (1999). However,
medical assistance was sought in only 10% of fatal cases reported by Zador et al.
(1996). It seems that along with discouraging solitary administration of heroin, the
engagement of the emergency services also needs to be promoted.
The Prison Service
The continuing drugs crisis within our prison service is again starkly highlighted by
the opiate-related deaths of two people in the current survey who were serving
sentences in Mountjoy. These come on top of a similar death in the 1998 survey and a
recently reported case, which will be included in the 2000 survey. However, these may
not be surprising giving the extent of the captive drug using population. The drug
treatment and rehabilitation regimes within our prison service need to brought up to at
least a comparable standard as that which exists in the wider community. There is an
argument that given the much higher percentage of drug users in this captive
population than in the community at large, a greater opportunity for intervention exists
within the prison service. ..
While imprisonment does not seem to increase the overall risk of injecting drug users
dying from overdose, the time immediately after release is one of intensified risk. This
is probably caused by a decrease in tolerance to drugs as a result of less frequent
injecting while in prison or the lower purity of drugs found in prison (Seaman et al.,
1998). The heightened mortality risk to this group re-entering the community was
previously noted by Strang et al. (1996).
Between the current and the 1998 survey 16 deaths in total are recorded of people who
were either recently released or were on temporary release from prison. In 9 of these
cases the length of time between release and death was given in evidence at inquest.
These range from one death on the day of release to another 8 weeks after release
(with an average of 3 weeks). Evidence was presented in another 5 cases that the
decedents were on temporary release and in the remaining 2 cases it was stated that
they were recently released from Prison.
Seaman et al. (1998) concluded that prisons should evaluate interventions to reduce
the risk of death from overdose after release. These interventions could include
providing an information sheet to prisoners who are about to be released and
improving communication between prison healthcare staff and external treatment
services and general practitioners.
• • • \
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Prevention Initiatives
It is clear that some opiate-related deaths are potentially preventable. A range of
relatively simple and for the most part inexpensive interventions could reduce the
incidence of such tragedies (WHO, 1998). These interventions include both improved
quality and range of services for and greater dissemination of risk factors to opiate
users
Risk Factor Education
Risk factor education of drug users and their peers can both prevent and improve the
management of opioid overdose (Darke and Zador, 1996). The mechanisms for .
delivering such information should be varied, timely, factual and non-judgemental. It
can be delivered during one-to-one contact or as a group activity.
Peer education projects focused on overdose prevention can also be successful in
promoting behavioural changes, which decrease individual risk. These projects
recognize the knowledge and expertise within the drug using community and utilize
the interactional processes that play out in users' everyday lives (Trautmann, 1995).
One such project initiated by the Australian Centre for Education and Information on
Drugs and Alcohol targeted a reduction in the frequency of overdosing by the creation
of support networks of drug users, knowledgeable in overdose prevention and
management. Together with past and present drug users they produced a booklet
called "Don't Mix With Your Fix" which provided information on overdosing
illustrated by stories about overdose experiences (CEIDA, 1997).
Drug users and their peers can be taught prevention strategies such as overdose
assessment, first aid and resuscitation techniques, and be encouraged to engage the
emergency services. The value of such skills can be placed in the context of
discouraging solitary administration. Safer drug using habits can also be promoted. An
indication of their personal tolerance to and the purity of the substance being used
may possibly be obtained, by using a smaller amount, by splitting the dose and by
injecting slowly. Finally such educational initiatives provide opportunities to promote
the avoidance of polydrug misuse, particularly the combinations of alcohol and
benzodiazepines with heroin or methadone (CEIDA, 1997).
Evaluation of Therapeutic Interventions
Notwithstanding the risks from lowered tolerance of those who leave treatment, it is
indisputable that there is minimal risk of overdosing within drug free treatments.
However, the majority of those in treatment are on opiate substitution programmes.
The role methadone maintenance plays in lowering the rate of opioid overdose
mortality and increasing the rate of methadone implication in such deaths was
discussed earlier. The onus is clearly on prescribers to continually review their
therapeutic interventions.
One valuable way of identifying shortcomings in treatment and contributory external
factors is by confidential enquiry. The medical care of all those who suffered a
methadone-related death in Glasgow in 1996 (n=34) was peer reviewed and the results
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of these assessments returned to the responsible clinicians (Scott et al, 1999).
Shortcomings in clinical care were identified in 5 6 % of cases and problems in the .
organisation of services in 69%. However, 8 5 % of doctors found the audit helpful and
the majority of them whose patient management attracted criticism intended to amend
their practice.
While such an enquiry would inevitably examine the roll of other drugs concurrently
implicated with methadone, the extent of the benzodiazepine implication in opiate-
related deaths in Dublin warrants independent investigation. If the benzodiazepine
prescribing audit recommended by Farrell et al. (2000) was conducted within and
external to the drug treatment services here it might help to ascertain the precise
extent of the problem and identify possible containment measures.
There are a number of alternatives to methadone, which may be more suitable in the
management of the opioid dependence of some of those at risk of overdose.
Buprenorphine seems to have been the most tested of these. Because of its longer
duration of action (which may allow for less than daily dosing) and the reduced risk of
overdose with buprenorphine, it may have some advantages over methadone (WHO, .
1998). Studies have shown buprenorphine to be as effective as methadone in reducing
illicit opioid use, retaining clients in treatment, in reducing withdrawal symptoms and
as a detoxification agent (Mattick et al, 1998).
However, in the context of the research presented here, the reduced abuse liability and
increased safety of buprenorphine is of most interest. Relative to methadone it
produces limited respiratory depression and is extremely well tolerated by non-
dependent humans (Walsh et al., 1994). Apparently it also greatly reduces the self-
reported drug effects of other opiates concurrently administered (Mattick et al., 1998)..
Increasing the dose of buprenorphine only has effects up to a certain level and this
translates into a greatly reduced chance of accidental or intentional overdose (NEDA,
1999).
In France there is a move towards buprenorphine and general practitioners prescribe it
to about one third of heroin users who consult them (EMCDDA, 1999). Worldwide
the risks of fatal overdose from buprenorphine are reported to be almost nil, except
where it is combined with other drugs (WHO, 1998). Deaths seem to have occurred
mainly from mixing buprenorphine and benzodiazepines (EMCDDA, 1999). This
point warrants caution in the light of the prevalence of benzodiazepine abuse here in
Dublin. However, because of the relative safety of buprenorphine as compared to
methadone, it should be considered as an alternative in some cases here and its
efficacy in protecting those most at risk of overdose tested.
Apart from the complete overhaul of the drug treatment services within our prisons,
the above overdose prevention strategies could be very easily implemented with
minimal additional expenditure, by and alongside services currently provided.
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An Alternative Opioid Treatment
Additional Interventions
Three controversial interventions were excluded from the above debate, partly
because of inherent implementation costs, but primarily to avoid distraction from the
more realizable options proposed. Firstly the international debate concerning the
prescribing of diamorphine as a maintenance substitute deserves consideration. This is
so particularly in the light of encouraging reduced mortality results from the Swiss
experiment (Uchtenhagen et al, 1997). Secondly, the debate into the distribution of
the antagonist naloxone to heroin users as a resuscitation agent warrants monitoring
(Strang et al, 1996; Strang et al, 1999). And finally, the provision of "safer" drug
using environments may reduce overdoses and the transmission of blood borne
infections. In Germany, Switzerland, the Netherlands and Australia "Fixing Rooms"
provide a hygienic and supervised environment for drug users to inject. This provides
opportunities for education and counselling and minimizes public nuisance (WHO,
1998). The above topics are presented as a flavour of the broad range of research
issues into opioid-related mortality prevention currently being debated.
Evidence Presented to Coroners at Inquests
In some jurisdictions in England and Wales, the Coroner requires that, where
methadone has been implicated in a death, any prescription for methadone shall be
presented in evidence at inquest. If this was to be stipulated at inquests here it might
help to determine the extent of methadone diversion from legitimate sources and
whatever role this might play in opiate-related deaths. Also, in the light of the
continued high rate of benzodiazepine abuse and its implication in the highest number
of opiate-related deaths in both 1998 and 1999, the presentation at inquests of
prescriptions for any medications prescribed to decedents before their deaths, may
help to clarify the role, if any, these drugs played in their deaths.
Conclusion
Coronial records are a valuable source of recent data on opioid-related deaths.
Detailed investigations of this data can provide insights into the nature and extent of
the problem and the efficacy of prevention and treatment strategies. Regular
monitoring of these records, alongside highlighting trends, could provide an early
warning of high-risk behaviour among specific population groups.
The profile of opioid-related deaths established in the first survey is repeated in 1999
and is consistent with comparable international research. The majority of decedents
were young (mean age, 29.73), male (male: female ratio - 8.55:1), single (75.6%) and
unemployed (70.9%). Benzodiazepines were again implicated in the highest number
of deaths (73.3%). There was a 9.17% increase and an 11.55% decrease in the number
of cases proving positive for heroin and methadone respectively. However, 90.71% of
cases had 2 or more drugs (mean, 3.38) implicated per death. The increased risk of
overdose among those recently released from prison was highlighted and the
heightened risk of suicide among opiate users was also discussed.
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The risk of opioid-related mortality is raised as the prevalence of opiate use increases.
However, fatalities solely involving opiates appear to form a minority of overdose
deaths. The major risk factors associated with opioid-related deaths are polydrug
misuse and fluctuations in individual tolerance. Greater availability and ease of access
to methadone maintenance may contribute to both a lower rate of opioid overdose
mortality and to a higher rate of methadone implication in such deaths. The challenge
. to service providers is to develop safer and more accessible methadone maintenance
regimen.
 :
It is clear that some opiate-related deaths are potentially preventable. Improved
dissemination of the risk factors, vigilant evaluation of therapeutic interventions and
consideration of internationally proven alternatives may help reduce the incidence of
such tragedies here. The competence of programmes in lowering the rate of opioid-
related deaths should be a major treatment efficacy benchmark. . . . . . .
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